Filing Details

Accession Number:
0001562180-22-000328
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-06 21:07:46
Reporting Period:
2022-01-05
Accepted Time:
2022-01-06 21:07:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1636422 Health Catalyst Inc. HCAT Services-Computer Programming, Data Processing, Etc. (7370) 453337483
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1780978 Paul Horstmeier C/O Health Catalyst, Inc.
10897 South River Front Parkway, #300
South Jordan UT 84095
Chief Operating Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-01-05 4,127 $15.84 100,825 No 4 M Direct
Common Stock Acquisiton 2022-01-05 6,623 $15.84 107,448 No 4 M Direct
Common Stock Disposition 2022-01-05 4,255 $35.89 103,193 No 4 S Direct
Common Stock Disposition 2022-01-05 4,999 $37.15 98,194 No 4 S Direct
Common Stock Disposition 2022-01-05 1,496 $38.04 96,698 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2022-01-05 6,623 $0.00 6,623 $15.84
Common Stock Stock Option (Right to Buy) Disposition 2022-01-05 4,127 $0.00 4,127 $15.84
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,769 2029-02-05 No 4 M Direct
47,901 2029-02-05 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 15, 2020, in accordance with Rule 10b5-1.
  2. Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $35.61 to $36.52, inclusive.
  3. Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $36.72 to $37.71, inclusive.
  4. Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $37.72 to $38.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) through (4).
  5. 25% of the 25,000 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on February 5, 2023.
  6. 25% of the 186,467 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on February 5, 2023.